Compliance Rate

Compliance Rate 51.23%
Compliant submissions 187
Incompliant submissions 178
Total trials 365

My Organizations' Clinical Trials

Showing 2025 of 2400 entries
View as:

Prevention of RSV Infections in Bone Marrow Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00001903 Org: User:
Start: 04/30/99 End: 05/31/01 Due: 05/31/02

A Study of Zidovudine in HIV-Infected Pregnant Women and Their Children

Phase: N/A Priority: Normal
NCT ID: NCT00001106 Org: User:
Start: - End: 03/31/94 Due: 03/31/95

Interferon as a Mucosal Adjuvant for Influenza Vaccine Given Intranasally

Phase: N/A Priority: Normal
NCT ID: NCT00436046 Org: User:
Start: 03/31/07 End: 10/31/07 Due: 10/31/08

Experimental Vaccine for Malaria in Adults in Mali

Phase: N/A Priority: Normal
NCT ID: NCT00343005 Org: User:
Start: 04/23/04 End: 01/22/08 Due: 01/22/09

A Study of HIV-Disease Development in Aging

Phase: N/A Priority: Normal
NCT ID: NCT00006144 Org: User:
Start: 10/31/00 End: 04/30/05 Due: 04/30/06

Fetal Immunity to Falciparum Malaria

Phase: N/A Priority: Normal
NCT ID: NCT00314899 Org: User:
Start: 09/15/06 End: 04/15/10 Due: 04/15/11

Anti-malaria MAb in Malian Children

Phase: N/A Priority: Normal
NCT ID: NCT05304611 Org: User:
Start: 03/18/22 End: 04/20/24 Due: 04/20/25

Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1

Phase: N/A Priority: Normal
NCT ID: NCT06517693 Org: User:
Start: 06/01/25 End: 06/30/28 Due: 06/30/29

Daclizumab to Treat Wegener's Granulomatosis

Phase: N/A Priority: Normal
NCT ID: NCT00040248 Org: User:
Start: 06/30/02 End: 05/31/05 Due: 05/31/06

Trial to Evaluate the Safety, Immunogenicity and Protective Efficacy of Three or Five Administrations of GAP3KO Sporozoites

Phase: N/A Priority: Normal
NCT ID: NCT03168854 Org: User:
Start: 07/26/17 End: 08/16/19 Due: 08/16/20

Safety of and Immune Response to Polyvalent HIV-1 Vaccine in HIV Uninfected Adults

Phase: N/A Priority: Normal
NCT ID: NCT00061243 Org: User:
Start: 04/30/04 End: 04/30/10 Due: 04/30/11

Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT02562482 Org: User:
Start: 11/18/15 End: 03/06/18 Due: 03/06/19

Handheld Computers to Improve Adherence to Anti-HIV Drug Regimens

Phase: N/A Priority: Normal
NCT ID: NCT00053443 Org: User:
Start: - End: 12/31/05 Due: 12/31/06

Collection of Plasma From People Who Recovered From or Were Vaccinated to Emerging Infectious Diseases

Phase: N/A Priority: Normal
NCT ID: NCT02338986 Org: User:
Start: 03/04/15 End: 05/15/25 Due: 05/15/26

Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen

Phase: N/A Priority: Normal
NCT ID: NCT00014937 Org: User:
Start: - End: - Due: -

GS-7977 With Ribavirin for Hepatitis C (SPARE)

Phase: N/A Priority: Normal
NCT ID: NCT01441180 Org: User:
Start: 09/30/11 End: 07/31/14 Due: 07/31/15

Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women

Phase: N/A Priority: Normal
NCT ID: NCT00592124 Org: User:
Start: 06/30/08 End: 07/31/10 Due: 07/31/11

Studies of Disorders With Increased Susceptibility to Fungal Infections

Phase: N/A Priority: Normal
NCT ID: NCT01222741 Org: User:
Start: 01/07/11 End: - Due: -

A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of Tuberculosis

Phase: N/A Priority: Normal
NCT ID: NCT00317330 Org: User:
Start: 12/31/04 End: 06/30/05 Due: 06/30/06

Study of Anti-HIV Therapy Intensification

Phase: N/A Priority: Normal
NCT ID: NCT00034086 Org: User:
Start: - End: 06/30/06 Due: 06/30/07

Evaluation and Follow-up of People With Tick-borne Diseases

Phase: N/A Priority: Normal
NCT ID: NCT04318925 Org: User:
Start: 11/13/23 End: 11/13/23 Due: 11/13/24

Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study

Phase: N/A Priority: Normal
NCT ID: NCT04311502 Org: User:
Start: 06/16/21 End: 06/24/24 Due: 06/24/25

Preventing Sexual Transmission of HIV With Anti-HIV Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00074581 Org: User:
Start: 02/28/05 End: 05/31/15 Due: 05/31/16

Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT03783130 Org: User:
Start: 03/07/19 End: 06/24/20 Due: 06/24/21

Anti-CD20 in Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT00036491 Org: User:
Start: 01/31/01 End: 01/31/06 Due: 01/31/07